<DOC>
	<DOCNO>NCT01197118</DOCNO>
	<brief_summary>Gastric cancer one prevalent malignancy China ; survival rate remain poor despite potentially curative resection . Complete surgical resection potentially curative therapy available patient gastric cancer . However , even complete resection negative margin , many patient experience recurrence . In recent year , radiation therapy carcinoma stomach represent new issue address accompany development radial physic radial biology , clinical application compute tomographic ( CT ) simulation digital reconstitution technique , especially application 3-dimensional conformal intensity modulate radiation therapy . Radiation therapy plus concurrent chemotherapy demonstrate cause significant improvement overall disease-free survival accord Intergroup Trial 0116/SWOG 9008 . So investigator design trial see whether postoperative sequence chemoradiotherapy include oxaliplatin fluorouracil-based regimen improve survival advanced gastric cancer .</brief_summary>
	<brief_title>Postoperative Sequence Chemoradiotherapy Compared With Chemotherapy Alone Advanced Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<criteria>1 . Postoperative histologically confirm advanced adenocarcinoma stomach gastroesophageal junction . 2 . Age 18 75 , Karnofsky score high 70 . 3 . Postoperative histologically conform metastasis perigastric lymph node and/or tumor invasion muscularis propria subserosa , without positive incisal margin . 4 . No severe functional damage major organ , normal blood cell , normal liver kidney function . 5 . No clinical finding distant metastasis . 6 . Predictive survival time longer 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>sequence chemoradiotherapy</keyword>
	<keyword>OLF regimen</keyword>
	<keyword>survival rate</keyword>
</DOC>